相似文献
1
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction.
Circulation. 2015 Nov 17;132(20):1880-90. doi: 10.1161/CIRCULATIONAHA.115.016160. Epub 2015 Sep 10.
2
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Cardiovasc Res. 2022 Oct 21;118(13):2778-2791. doi: 10.1093/cvr/cvab337.
3
P2Y-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction.
Basic Res Cardiol. 2022 Mar 30;117(1):16. doi: 10.1007/s00395-022-00927-6.
4
E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction.
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1802-8. doi: 10.1161/ATVBAHA.116.307519. Epub 2016 Jul 28.
5
Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease.
Nat Cardiovasc Res. 2022 Jan;1(1):28-44. doi: 10.1038/s44161-021-00002-8. Epub 2021 Dec 23.
6
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
J Am Coll Cardiol. 2018 Feb 27;71(8):875-886. doi: 10.1016/j.jacc.2017.12.037.
7
Bone marrow NLRP3 inflammasome-IL-1β signal regulates post-myocardial infarction megakaryocyte development and platelet production.
Biochem Biophys Res Commun. 2021 Dec 31;585:96-102. doi: 10.1016/j.bbrc.2021.11.031. Epub 2021 Nov 11.
8
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.
J Mol Med (Berl). 2018 Jun;96(6):559-573. doi: 10.1007/s00109-018-1641-x. Epub 2018 May 8.
9
Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.
J Mol Cell Cardiol. 2014 Apr;69:32-42. doi: 10.1016/j.yjmcc.2014.01.015. Epub 2014 Feb 5.
10
Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells.
PLoS One. 2013 Oct 1;8(10):e76206. doi: 10.1371/journal.pone.0076206. eCollection 2013.
引用本文的文献
1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Firsekibart, an Anti-interleukin-1β Monoclonal Antibody, in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
Adv Ther. 2025 Jul 25. doi: 10.1007/s12325-025-03279-4.
2
A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure.
Heart Fail Rev. 2025 May 14. doi: 10.1007/s10741-025-10519-w.
3
CCR2 dependent recruited pro-inflammatory monocytes contribute to the development of left ventricular hypertrophy in mice upon transverse aortic constriction.
PLoS One. 2025 Apr 21;20(4):e0318407. doi: 10.1371/journal.pone.0318407. eCollection 2025.
4
Modulation of bone marrow haematopoietic stem cell activity as a therapeutic strategy after myocardial infarction: a preclinical study.
Nat Cell Biol. 2025 Apr;27(4):591-604. doi: 10.1038/s41556-025-01639-4. Epub 2025 Apr 2.
5
Emerging Role of Macrophage-Fibroblast Interactions in Cardiac Homeostasis and Remodeling.
JACC Basic Transl Sci. 2024 Aug 14;10(1):113-127. doi: 10.1016/j.jacbts.2024.06.003. eCollection 2025 Jan.
6
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.
Circ Res. 2025 Jan 31;136(3):325-353. doi: 10.1161/CIRCRESAHA.124.323778. Epub 2025 Jan 30.
7
Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy.
bioRxiv. 2024 Dec 17:2024.12.11.628020. doi: 10.1101/2024.12.11.628020.
8
Functional diversity of cardiac macrophages in health and disease.
Nat Rev Cardiol. 2025 Jun;22(6):431-442. doi: 10.1038/s41569-024-01109-8. Epub 2025 Jan 2.
9
Myocardial infarction augments sleep to limit cardiac inflammation and damage.
Nature. 2024 Nov;635(8037):168-177. doi: 10.1038/s41586-024-08100-w. Epub 2024 Oct 30.
10
Association between Inflammation and New-Onset Atrial Fibrillation in Acute Coronary Syndromes.
J Clin Med. 2024 Aug 27;13(17):5088. doi: 10.3390/jcm13175088.
本文引用的文献
1
Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells.
Cell Stem Cell. 2015 May 7;16(5):477-87. doi: 10.1016/j.stem.2015.04.008.
2
SnapShot: The hematopoietic stem cell niche.
Cell. 2014 Jul 3;158(1):228-228.e1. doi: 10.1016/j.cell.2014.06.019.
3
Chronic variable stress activates hematopoietic stem cells.
Nat Med. 2014 Jul;20(7):754-758. doi: 10.1038/nm.3589. Epub 2014 Jun 22.
4
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity.
Cell Metab. 2014 May 6;19(5):821-35. doi: 10.1016/j.cmet.2014.03.029.
5
The inflammatory response in myocardial injury, repair, and remodelling.
Nat Rev Cardiol. 2014 May;11(5):255-65. doi: 10.1038/nrcardio.2014.28. Epub 2014 Mar 25.
6
Macrophages are required for neonatal heart regeneration.
J Clin Invest. 2014 Mar;124(3):1382-92. doi: 10.1172/JCI72181. Epub 2014 Feb 24.
7
The bone marrow niche for haematopoietic stem cells.
Nature. 2014 Jan 16;505(7483):327-34. doi: 10.1038/nature12984.
8
The interleukin-1 family: back to the future.
Immunity. 2013 Dec 12;39(6):1003-18. doi: 10.1016/j.immuni.2013.11.010.
9
Targeting interleukin-1 in heart disease.
Circulation. 2013 Oct 22;128(17):1910-23. doi: 10.1161/CIRCULATIONAHA.113.003199.
10
IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium.
J Immunol. 2013 Nov 1;191(9):4838-48. doi: 10.4049/jimmunol.1300725. Epub 2013 Sep 27.
Zotero 插件